Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$6.16 - $12.07 $677,544 - $1.33 Million
-109,991 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$9.7 - $14.34 $4.18 Million - $6.18 Million
-431,009 Reduced 79.67%
109,991 $1.11 Million
Q2 2021

Aug 16, 2021

BUY
$13.43 - $19.16 $7.27 Million - $10.4 Million
541,000 New
541,000 $7.67 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $705M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.